37 related articles for article (PubMed ID: 26080829)
1. Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer.
Lu CS; Shieh GS; Wang CT; Su BH; Su YC; Chen YC; Su WC; Wu P; Yang WH; Shiau AL; Wu CL
Oncotarget; 2017 May; 8(19):30844-30858. PubMed ID: 27244887
[TBL] [Abstract][Full Text] [Related]
2. Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells.
Matsumoto N; Ebihara M; Oishi S; Fujimoto Y; Okada T; Imamura T
Sci Rep; 2021 Jan; 11(1):1492. PubMed ID: 33452347
[TBL] [Abstract][Full Text] [Related]
3. FOXO1 inactivation induces cisplatin resistance in bladder cancer.
Ide H; Goto T; Teramoto Y; Mizushima T; Jiang G; Nagata Y; Inoue S; Baras AS; Kashiwagi E; Miyamoto H
Cancer Sci; 2020 Sep; 111(9):3397-3400. PubMed ID: 32678492
[TBL] [Abstract][Full Text] [Related]
4. NPEPPS Is a Druggable Driver of Platinum Resistance.
Jones RT; Scholtes M; Goodspeed A; Akbarzadeh M; Mohapatra S; Feldman LE; Vekony H; Jean A; Tilton CB; Orman MV; Romal S; Deiter C; Kan TW; Xander N; Araki SP; Joshi M; Javaid M; Clambey ET; Layer R; Laajala TD; Parker SJ; Mahmoudi T; Zuiverloon TCM; Theodorescu D; Costello JC
Cancer Res; 2024 May; 84(10):1699-1718. PubMed ID: 38535994
[TBL] [Abstract][Full Text] [Related]
5. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer.
Li F; Zhang H; Huang Y; Li D; Zheng Z; Xie K; Cao C; Wang Q; Zhao X; Huang Z; Chen S; Chen H; Fan Q; Deng F; Hou L; Deng X; Tan W
Drug Resist Updat; 2024 Mar; 73():101059. PubMed ID: 38295753
[TBL] [Abstract][Full Text] [Related]
6. GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer.
Elahi Najafi MA; Yasui M; Teramoto Y; Tatenuma T; Jiang G; Miyamoto H
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762034
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells.
Schmidtova S; Kalavska K; Gercakova K; Cierna Z; Miklikova S; Smolkova B; Buocikova V; Miskovska V; Durinikova E; Burikova M; Chovanec M; Matuskova M; Mego M; Kucerova L
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31443351
[TBL] [Abstract][Full Text] [Related]
8. Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients.
Kong J; Lee H; Kim D; Han SK; Ha D; Shin K; Kim S
Nat Commun; 2020 Oct; 11(1):5485. PubMed ID: 33127883
[TBL] [Abstract][Full Text] [Related]
9. Plasmonic laser-responsive BioDissolve 3D-printed graphene@cisplatin-implant for prevention of post-surgical relapse of oral cancer.
Anup N; Gadeval A; Ramdas Mule S; Gupta T; Kumar Tekade R
Int J Pharm; 2024 Apr; 657():124123. PubMed ID: 38621618
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomy.
Sari Motlagh R; Schuettfort VM; Mori K; Katayama S; Rajwa P; Aydh A; Grossmann NC; Laukhtina E; Pradere B; Mostafai H; Quhal F; Abufaraj M; Lee R; Karakiewicz PI; Lotan Y; Comprate E; Moschini M; Gontero P; Shariat SF
Int J Urol; 2022 Jul; 29(7):676-683. PubMed ID: 35368130
[TBL] [Abstract][Full Text] [Related]
11. Glucose-Regulated Protein 94 Mediates the Proliferation and Metastasis through the Regulation of ETV1 and MAPK Pathway in Colorectal Cancer.
Batzorig U; Wei PL; Wang W; Huang CY; Chang YJ
Int J Med Sci; 2021; 18(11):2251-2261. PubMed ID: 33967600
[TBL] [Abstract][Full Text] [Related]
12. IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells.
Tang Z; Gillatt D; Rowe E; Koupparis A; Holly JMP; Perks CM
Oncotarget; 2019 Dec; 10(66):7043-7057. PubMed ID: 31903164
[TBL] [Abstract][Full Text] [Related]
13. Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder Cancer.
Lin YH; Tsui KH; Chang KS; Hou CP; Feng TH; Juang HH
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861435
[TBL] [Abstract][Full Text] [Related]
14. IGFBP2 plays an important role in heat shock protein 27-mediated cancer progression and metastasis.
Hung CS; Huang CY; Lee CH; Chen WY; Huang MT; Wei PL; Chang YJ
Oncotarget; 2017 Aug; 8(33):54978-54992. PubMed ID: 28903396
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin.
Zhu H; Yun F; Shi X; Wang D
Int J Mol Med; 2015 Aug; 36(2):595-601. PubMed ID: 26080829
[TBL] [Abstract][Full Text] [Related]
16. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
Zhu H; Yun F; Shi X; Wang D
Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
[TBL] [Abstract][Full Text] [Related]
17. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane inhibits the proliferation of the BIU87 bladder cancer cell line via IGFBP-3 elevation.
Dang YM; Huang G; Chen YR; Dang ZF; Chen C; Liu FL; Guo YF; Xie XD
Asian Pac J Cancer Prev; 2014; 15(4):1517-20. PubMed ID: 24641360
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
